Panasonic Corp sold its stake in Tesla Inc for about $3.61 billion in the year ended March, to reduce its dependence on the electric carmaker and raise cash for investing in growth.
The Japanese conglomerate acquired 1.4 million Tesla shares at $21.15 each in 2010 for about $30 million. The stake was worth $730 million at the end of March 2020 and has gained almost sevenfold since then.
It was worth $679.82 per share on Thursday.
While the stake sale will not affect the partnership between the two firms, Tesla is diversifying its battery supply chain.
Panasonic, whose battery business is dominated by Tesla, intends to buy more shares in US supply-chain software company Blue Yonder, in a $7.1 billion deal.


Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



